Cleveland Clinic, Mount Sinai not administering new Alzheimer's drug | The Hill: Healthcare Policy

The Cleveland Clinic and the Mount Sinai Health System, two major health systems in the U.S., have decided they would not administer Biogen’s new Alzheimer’s drug following the Food and Drug Administration’s (FDA) controversial approval. The...